Matt Larew
Stock Analyst at William Blair
(0.31)
# 4,035
Out of 4,711 analysts
12
Total ratings
28.57%
Success rate
-29.66%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRVI Maravai LifeSciences Holdings | Downgrades: Market Perform | n/a | $5.37 | - | 1 | Nov 8, 2024 | |
| AMED Amedisys | Downgrades: Market Perform | n/a | $84.47 | - | 1 | Jul 1, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Underperform | n/a | $10.08 | - | 3 | May 10, 2024 | |
| ATR AptarGroup | Upgrades: Outperform | n/a | $158.18 | - | 1 | Apr 29, 2024 | |
| TECH Bio-Techne | Initiates: Outperform | n/a | $73.17 | - | 1 | Aug 28, 2023 | |
| AVTR Avantor | Downgrades: Market Perform | n/a | $21.21 | - | 1 | Jul 31, 2023 | |
| INNV InnovAge Holding | Downgrades: Market Perform | n/a | $4.19 | - | 2 | Sep 22, 2021 | |
| MXCT MaxCyte | Initiates: Outperform | n/a | $4.24 | - | 1 | Aug 24, 2021 | |
| TWST Twist Bioscience | Initiates: Outperform | n/a | $47.94 | - | 1 | Jun 29, 2021 |
Maravai LifeSciences Holdings
Nov 8, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $5.37
Upside: -
Amedisys
Jul 1, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $84.47
Upside: -
Ginkgo Bioworks Holdings
May 10, 2024
Downgrades: Underperform
Price Target: n/a
Current: $10.08
Upside: -
AptarGroup
Apr 29, 2024
Upgrades: Outperform
Price Target: n/a
Current: $158.18
Upside: -
Bio-Techne
Aug 28, 2023
Initiates: Outperform
Price Target: n/a
Current: $73.17
Upside: -
Avantor
Jul 31, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.21
Upside: -
InnovAge Holding
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.19
Upside: -
MaxCyte
Aug 24, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.24
Upside: -
Twist Bioscience
Jun 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $47.94
Upside: -